A prospective double-blind study was conducted to compare the anti-emetic efficacy of ondansetron and droperidol in preventing postoperative emesis following strabismus surgery. A sample size of 213 patients was divided into three equal groups to receive ondansetron 150 }lglkg (Group A), ondansetron 75 }lglkg (Group B), or droperidol 75 }lglkg (Group C). All patients received a standardized anaesthetic technique. All episodes of emesis, recovery time, and time to tolerating oral fluids were recorded.
strabismus repair were randomly allocated to one of three groups: Group A received ondansetron 150 }lg/kg, Group B received ondansetron 75 }lg/kg, and Group C received droperidol 75 }lg/kg. The sample size was calculated on the basis of an average emesis value of 300/0 reported to occur with the use of droperidol when used as an anti-emetic following strabismus surgeryl. To detect a difference of up to 200/0 in the efficacy between ondansetron and droperidol, at a confidence level of 95% and power of 80%, a sample size of 71 for each group was necessary.
There were no criteria for exclusion from the study-those patients with a history of motion sickness or previous postoperative vomiting were not excluded.
All patients were allowed solid and milk up to six hours and clear fluids up to two hours before surgery. No attempt was made to empty the stomach at any time during the procedure. All cases received an intravenous infusion of Ringers lactate at induction. An initial bolus of 10 mllkg was followed by an infusion of 2 mllkg/hour. This was continued until the patient was drinking postoperatively.
Each anti-emetic was diluted to a total of 10 ml with normal saline and injected over a five-minute period prior to commencement of surgery. In all cases, the observer and the administrator were blinded as to the nature of the anti-emetic injected.
All patients received a standardized anaesthetic technique. Premedication consisted of oral midazolam syrup, 0.5 mg/kg for children up to a maximum of 10 mg and oral diazepam, 5-10 mg for adults. Induction was by thiopentone, 4 mg/kg intravenously or gaseous using halothane in small children. Glycopyrrolate, 5 p.g/kg was given to all patients. Care was taken not to inflate the stomach during the induction period.
Anaesthesia was maintained with nitrous oxide and isoflurane 1-1.51110. Atracurium 0.5 mg/kg was used for intubation and ail patients were ventilated with a tidal volume of 10 mIlkg. Minute volume and fresh gas flow were adjusted to maintain an end-tidal carbon dioxide level of 35-40 mmHg. Analgesia was provided by intravenous fentanyl 2 p.g/kg and diclofenac suppository (1.5 mg/kg). Ail patients were allowed to revert to spontaneous respiration at the end of the procedure and were extubated without the use of reversal agents, as indicated by the use of a peripheral nerve stimulator.
In the recovery area and for the following 24 hours any emetic episode (defined as a single vomit, retch, series of vomits or retches occurring within anyone minute period) was recorded. Total recovery time was taken from extubation until reaching a score of 5 on the recovery index scale (Table 1) . The frequency of emesis was compared between the three treatment groups. Parametric (one way ANOVA) and nonparametric Kruskal-WaIIis tests were used to show any difference between the number of emetic episodes at 4, 8, 12, or 24 hours among the three groups and to determine variability between the three treatment groups with respect to age, gender, length of procedures, number of muscles operated and recovery times in each of the three groups. A value of P< 0.05 was taken to be statistically significant.
RESULTS
There were no statistically significant differences in patient characteristics or operative procedure between groups ( No statistical significant difference is found when the total number of emetic episodes per patient is compared between groups (Figure 2 ). No patient in Group B had more than two emetic episodes whereas Groups A and C had patients suffering more than two emetic episodes.
Mean discharge times from recovery were 75.3 minutes (Groups A), 44.4 minutes (Group B), and 41.0 minutes (Group C). The mean time to tolerating oral fluids was 356.5 minutes (Group A), 402.8 minutes (Group B), and 378.1 minutes (Group C) ( Figure 3 ). There is no significant difference between the groups (P=O. 4) .
No side-effects involving the central nervous system or gastrointestinal tract were observed.
DISCUSSION
Emesis remains a major postoperative complication, despite recent advances in therapy!o. Emesis following strabismus surgery has a particularly high incidence of 41-88% in those patients who have not received any anti-emetic therapy!. It was felt that this made the inclusion of a placebo group unjustified. This high incidence of emesis has been the basis for the postulated existence of the oculo-emetic reflex whereby manipulation of the eye muscles causes central neurotransmitter release (dopamine, histamine, acetylcholine and 5-hydroxytryptamine) in the chemoreceptor trigger zone located in the area postrema of the medulla 4 • It is the inhibition of these transmitters and their relay to the vomiting centre that forms the basis of current anti-emetic therapy. The two dosage levels of ondansetron (Groups A and B) were used to compare the clinical effectiveness of the two amounts. Ondansetron is a highly selective antagonist at 5-hydroxytryptamine (5-HT3) receptor sites located centrally and peripherally in the gastrointestinal tract where it blocks 5-HT 3 receptors in the mucosal vagal afferents, thereby blocking the emetic loop.
The use of ondansetron in the control of postoperative emesis has been evaluated in at least 16 placebo-controlled studies since 1991"·25. It apears to be a safe and effective agent but few studies to date have compared it with existing anti-emetics 26 . 1' • Grant, Collis and Hetreed'2 could find no statistical difference between ondansetron and droperidol in preventing postoperative nausea and vomiting in patients undergoing major orthopaedic procedures.
The increase in time to reach the recovery index score with Group A may represent a central sedative effect of ondansetron in the higher dosage range. Rose et al found ondansetron in a dose of 150 /tg/kg was superior to placebo in reducing the incidence and severity of emesis up to 24 hours after strabismus surgery". Our study shows that the anti-emetic effect of 75 /tg/kg of ondansetron is as effective as 150 /tg/kg when compared with droperidol. Paterson et al compared Anaesthesia and Intensive Care, Vol. 13, No. 4, August, 1995 droperidol with ondansetron in the prevention of strabismus-induced emesis and found ondansetron clinically superior34. The difference was not statistically significant however, because of the small sample size of 37 patients. In a recent article, Rose et al compared ondansetron with metoclopramide and placebo in reducing post-strabismus emesis and while clearly superior to placebo, ondansetron was not significantly better than metoclopramide in reducing emesis's. While extrapyramidal reactions were not observed in initial clinical trials with ondansetron'6, Halperin and Murphy'7 published a case report of extrapyramidal complications which indicate a potential for dystonictype reactions. However, no side-effects were noted in our trial.
In this study we were able to demonstrate that ondansetron is as effective as droperidol (but not statistically better) in preventing post-strabismus emesis. All three groups provided a satisfactory level of anti-emetic protection when compared with existing regimens'·'. It appears that 75 /tg/kg of ondansetron results in better clinical outcomes than higher doses in terms of less multiple emetic episodes and shorter immediate recovery time. Whether our incidence of emesis could be lowered by altering our standard anaesthetic technique to include propofol, exclude nitrous oxide and include the use of local anaesthesia, will form the basis of a future study.
The lower incidence of multiple emetic episodes in Group B may reflect the decreased number of females in this group. However the role of cyclical hormone changes and their contribution to postoperative emesis remains unclear 'o .
The multifactorial aetiology of postoperative emesis indicates the potential for combination anti-emetic therapy, particularly in those procedures with a known high incidence of emesis and in patients with a history of severe postoperative emesis following any surgical procedure" .
In conclusion there were no statistical differences between ondansetron at 75 or 150 jLg/kg and droperidol at 75 jLg/kg as anti-emetics following a standardized anaesthetic technique in strabismus correction. All three preparations provided an acceptable level of anti-emetic protection with the lower dosage of ondansetron being as effective as the higher dosage, when compared with droperidol. There was no significant difference in recovery times between groups and all groups showed an absence of side-effects from the anti-emetic administered.
